From Casetext: Smarter Legal Research

McKesson Corp. v. Opharma Grp.

United States District Court, Middle District of Florida
Jan 3, 2022
6:21-cv-422-RBD-GJK (M.D. Fla. Jan. 3, 2022)

Opinion

6:21-cv-422-RBD-GJK

01-03-2022

MCKESSON CORPORATION, Plaintiff, v. OPHARMA GROUP LLC; EDELMIRA LARA; and FREDERICK SMITH, Defendants.


ORDER

ROY B. DALTON JR., United States District Judge

Before the Court are:

1. Unopposed Motion for Entry of Final Judgment in Favor of Plaintiff and Against Defendant Susan Schleifer Consistent with the Terms of Mediated Settlement (Doc. 69 (“Motion”)); and.
2. U.S. Magistrate Judge Gregory J. Kelly's Report and Recommendation (Doc. 71 (“R&R”)).

In this breach of contract case, Plaintiff and Defendant Susan Schleifer reached an agreement after mediation. (See Doc. 69, ¶¶ 1, 4-5.) Plaintiff now requests that the Court enter final judgment against Schleifer. (Id. ¶ 8.) On referral, Judge Kelly recommends granting the Motion and entering final judgment in accordance with the terms of the settlement. (Doc. 71, p. 2.)

The parties did not object to the R&R and the time for doing so has passed, so the Court examines the R&R for clear error only. See Macort v. Prem, Inc., 208 Fed.Appx. 781, 784 (11th Cir. 2006). Finding none, the R&R is due to be adopted.

Accordingly, it is ORDERED AND ADJUDGED:

1. The R&R (Doc. 71) is ADOPTED, CONFIRMED, and made a part of this Order in its entirety.
2. Plaintiffs Motion (Doc. 69) is GRANTED.
3. The Clerk is DIRECTED to enter final judgment in favor of Plaintiff and against Susan Schleifer in the amount of $219,556.88.

DONE AND ORDERED.


Summaries of

McKesson Corp. v. Opharma Grp.

United States District Court, Middle District of Florida
Jan 3, 2022
6:21-cv-422-RBD-GJK (M.D. Fla. Jan. 3, 2022)
Case details for

McKesson Corp. v. Opharma Grp.

Case Details

Full title:MCKESSON CORPORATION, Plaintiff, v. OPHARMA GROUP LLC; EDELMIRA LARA; and…

Court:United States District Court, Middle District of Florida

Date published: Jan 3, 2022

Citations

6:21-cv-422-RBD-GJK (M.D. Fla. Jan. 3, 2022)